Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients

被引：0
|
作者：
Eiji Shinto
Eiji Oki
Mototsugu Shimokawa
Shigeki Yamaguchi
Megumi Ishiguro
Seiji Hasegawa
Yasumasa Takii
Hideyuki Ishida
Tetsuya Kusumoto
Masaru Morita
Naohiro Tomita
Manabu Shiozawa
Masafumi Tanaka
Heita Ozawa
Yojiro Hashiguchi
Shinobu Ohnuma
Sachiyo Tada
Tomoko Matsushima
Keisuke Yamagishi
Kazuo Hase
机构：
[1] National Defense Medical College,Department of Surgery
[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
[3] Yamaguchi University Graduate School of Medicine,Department of Biostatistics
[4] Tokyo Women’s Medical University,Department of Surgery, Division of Colorectal Surgery
[5] Tokyo Medical and Dental University,Medical Innovation Promotion Center
[6] Saiseikai Yokohamashi Nanbu Hospital,Department of Surgery
[7] Niigata Cancer Center Hospital,Department of Gastroenterological Surgery
[8] Saitama Medical Center,Department of Digestive Tract and General Surgery
[9] Saitama Medical University,Department of Gastroenterological Surgery, Clinical Research Center, Cancer Research Division
[10] National Hospital Organization Kyushu Medical Center,Department of Gastroenterological Surgery
[11] National Hospital Organization Kyushu Cancer Center,Cancer Treatment Center
[12] Toyonaka Municipal Hospital,Department of Gastrointestinal Surgery
[13] Kanagawa Cancer Center,Coloproctology Center
[14] Takano Hospital,Department of Colorectal Surgery
[15] Tochigi Cancer Center,Department of Surgery
[16] Teikyo University School of Medicine,Department of Surgery
[17] Tohoku University Hospital,LS Business
[18] Sysmex Corporation,undefined
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5239 / 5247
页数：8
相关论文
共 50 条
  • [41] Recurrence risk analysis for stage II and III colorectal cancer, and the implications of diabetes mellitus as a risk factor for the recurrence of stage III colorectal cancer
    Kimura, Naoya
    Hiraki, Masatsugu
    Furukawa, Shunsuke
    Okuyama, Keiichiro
    Kohya, Naohiko
    Sakai, Masashi
    Kawaguchi, Atsushi
    Ikubo, Akashi
    Samejima, Ryuichiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (06)
  • [42] Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
    Lurje, Georg
    Zhang, Wu
    Yang, Dongyun
    Groshen, Susan
    Hendifar, Andrew E.
    Husain, Hatim
    Nagashima, Fumio
    Chang, Heung M.
    Fazzone, William
    Ladner, Robert D.
    Pohl, Alexandra
    Ning, Yan
    Iqbal, Syma
    El-Khoueiry, Anthony
    Lenz, Heinz-Josef
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (02): : 161 - 168
  • [43] Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.
    Bohanes, Pierre Oliver
    Yang, Dongyun
    Loupakis, Fotios
    Labonte, Melissa Janae
    Gerger, Armin
    Ning, Yan
    Wakatsuki, Takeru
    Zhang, Wu
    Benhaim, Leonor
    Paez, David
    El-Khoueiry, Anthony B.
    El-Khoueiry, Rita
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Western diet is associated with a higher risk of recurrence of stage III colon cancer
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (11): : 589 - 589
  • [45] Risk Stratification in Patients with Stage II Colon Cancer
    Amri, Ramzi
    England, Jonathan
    Bordeianou, Liliana G.
    Berger, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 3907 - 3914
  • [46] Risk Stratification in Patients with Stage II Colon Cancer
    Ramzi Amri
    Jonathan England
    Liliana G. Bordeianou
    David L. Berger
    Annals of Surgical Oncology, 2016, 23 : 3907 - 3914
  • [47] Use of a combination of CEA and tumor budding to identify high-risk patients with stage II colon cancer
    Du, Changzheng
    Xue, Weicheng
    Dou, Fangyuan
    Peng, Yifan
    Yao, Yunfeng
    Zhao, Jun
    Gu, Jin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (03): : E267 - E273
  • [48] GCC expression in lymph nodes (LNs) as a significant determinant of recurrence in stage II colon cancer (CC) patients (pts)
    Sargent, D. J.
    Shi, Q.
    Bot, B. M.
    Resnick, M. B.
    Meyers, M. O.
    Goldar-Najafi, A.
    Clancy, T. E.
    Gill, S.
    Siemons, G. O.
    Fradet, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy
    Dolores Giraldez, Maria
    Jose Lozano, Juan
    Cuatrecasas, Miriam
    Alonso-Espinaco, Virginia
    Maurel, Joan
    Marmol, Maribel
    Hoerndler, Carlos
    Ortego, Javier
    Alonso, Vicente
    Escudero, Pilar
    Ramirez, Gina
    Petry, Christoph
    LaSalvia, Luis
    Bohmann, Kerstin
    Wirtz, Ralph
    Mira, Aurea
    Castells, Antoni
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1090 - 1097
  • [50] Metformin and risk recurrence in resected stage II/III colon cancer (CC) patients (pts): subgroup analysis from the TOSCA trial
    Di Bartolomeo, M.
    Rosato, G.
    Banzi, M.
    Pella, N.
    Zampino, M. G.
    Rimassa, L.
    Maiello, E.
    Marchetti, P.
    Lonardi, S.
    Labianca, R.
    Zaniboni, A.
    Sobrero, A.
    Ferrari, D.
    Bidoli, P.
    Iaffaioli, V.
    De Placido, S.
    Frassineti, L.
    Frustaci, S.
    Nicolini, M.
    Vernieri, C.
    Galli, F.
    ANNALS OF ONCOLOGY, 2017, 28
12345